Persones / Equip Humà

Clàudia Fortuny Guasch

Buscador de publicacions

Publicacions

  • Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A and Fortuny-Guasch C.

    Off-label use of dalbavancin in children: a case series.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067.

    [doi:10.1093/jac/dkae212]

  • Pons-Tomàs G, Pino-Ramirez RM, Soler-García a, Launes-Montana C, Irene Martínez de Albéniz, Rios-Barnés M, Melé-Casas M, Hernández-García M, Manuel Monsonis Cabedo, Gene-Giralt A, Fernández de Sevilla-Estrach M, García-García JJ, Fortuny-Guasch C and Fumadó V.

    Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations.

    Pathogens . 13(8): .

    [doi:10.3390/pathogens13080622]

  • Pons-Tomas, Gemma, Hernandez-Garcia, Maria, Mele-Casas, Maria, Fernández de Sevilla-Estrach M, Launes-Montana C, Girona M, Rios-Barnés M, Bassat Q, Ajanovic, Sara, Cubells M, Claverol J, Penela-Sanchez, Daniel, Jou-Munoz C, Manuel Monsonis Cabedo, Esteva-Afonso C, Fassanella, Assumpta, Cuadras-Palleja D, Munoz-Almagro C, Jordán-García I, Fortuny-Guasch C, García-García JJ and Fumadó V.

    Clinical Characterization, Transmissibility, and Seroconversion of SARS-CoV-2 Infection in Children (before the Start of Vaccination) in the Barcelona Metropolitan Region (Spain)

    Journal of Pediatric Infectious Diseases . : .

    [doi:10.1055/s-0044-1787676]

  • Agüera M, Soler-García a, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C.

    Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): .

    [doi:10.1111/pai.14175]

  • Epalza, C, Valadés-Alcaraz, A, González-Alba, JM, Beltrán-Pavez, C, Gutiérrez-López, M, Rubio-Garrido, M, Fortuny-Guasch C, Frick, MA, Medina, LM, Moreno, S, Sanz, J, Rojo, P, Navarro, ML and Holguín, A.

    Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(1): 40-48.

    [doi:10.1097/INF.0000000000004138]

  • Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny-Guasch C, Armangue-Salvador T, Dalmau JO, Querol L and Saiz A.

    mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 10(6): . Nº de cites: 2

    [doi:10.1212/NXI.0000000000200163]

  • Soler-García a, Gamell Fullà A, Manuel Monsonis Cabedo, Korta-Murua JJ, Espiau M, Rincón-López E, Rodríguez-Molino P, Pérez-Porcuna T, Bustillo-Alonso M, Santiago B, Tebruegge M and Noguera-Julián A.

    The Value of the Second QuantiFERON-TB Gold-Plus Antigen Tube at Diagnosis and at Treatment Completion in Spanish Children With Tuberculosis.

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 42(11): 1017-1020. Nº de cites: 1

    [doi:10.1097/INF.0000000000004058]

  • Armangue-Salvador T, Olivé-Cirera G, Martínez-Hernandez E, Rodes M, Peris-Sempere V, Guasp M, Ruiz R, Palou E, González A, Marcos MÁ, Erro ME, Bataller L, Corral-Corral Í, Planagumà J, Caballero E, Vlagea A, Chen J, Bastard P, Materna M, Marchal A, Abel L, Cobat A, Alsina L, Fortuny-Guasch C, Saiz A, Mignot E, Vanderver A, Casanova JL, Zhang SY and Dalmau J.

    Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies.

    BRAIN . 146(10): 4306-4319. Nº de cites: 18

    [doi:10.1093/brain/awad238]

  • Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny-Guasch C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM and Ford D.

    Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

    LANCET CHILD & ADOLESCENT HEALTH . 7(10): 718-727.

    [doi:10.1016/S2352-4642(23)00164-5]

  • Alarcon A, de Vries LS, Parodi A, Arnáez J, Cabañas F, Steggerda SJ, Rebollo M, Ramenghi L, Dorronsoro I, López-Azorín M, Schneider J, Noguera-Julián A, Rios-Barnés M, Recio M, Bickle-Graz M, Martínez-Biarge M, Fortuny-Guasch C, García-Alix A and Truttmann AC.

    Neuroimaging in infants with congenital cytomegalovirus infection and its correlation with outcome: emphasis on white matter abnormalities

    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION . 109(2): 151-158. Nº de cites: 5

    [doi:10.1136/archdischild-2023-325790]